Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis

Holly Rosenzweig, M. M. Jann, T. T. Glant, Tammy Martin, Stephen Planck, W. Van Eden, P. J S Van Kooten, R. A. Flavell, K. S. Kobayashi, James (Jim) Rosenbaum, Michael Davey

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In addition to its role in innate immunity, nucleotide oligomerization domain 2 (NOD2) has been shown to play a suppressive role in models of colitis. Notably, mutations in NOD2 cause the inherited granulomatous disease of the joints called Blau syndrome, thereby linking NOD2 with joint disease as well. However, the role of NOD2 in joint inflammation has not been clarified. We demonstrate here that NOD2 is functional within the mouse joint and promotes inflammation, as locally or systemically administered muramyl dipeptide (MDP; the NOD2 agonist) resulted in significant joint inflammation that was abolished in NOD2-deficient mice. We then sought to investigate the role of NOD2 in a mouse model of inflammatory arthritis dependent on adaptive immunity using TCR-transgenic mice whose T cells recognized the dominant epitope of proteoglycan (PG). Mice immunized with PG in the presence of MDP developed a more severe inflammatory arthritis and histopathology within the joints. Antigen-specific activation of splenocytes was enhanced by MDP with respect to IFN-γ production, which would be consistent with the Th1-mediated disease in vivo. Intriguingly, NOD2 deficiency did not alter the PGinduced arthritis, indicating that NOD2 does not play an essential role in this model of joint disease when it is not activated by MDP. In conclusion, we demonstrate that in a model of inflammatory arthritis dependent on T and B cell priming, NOD2 activation potentiates disease. However, the absence of NOD2 does not alter the course of inflammatory arthritis, in contrast to models of intestinal inflammation.

Original languageEnglish (US)
Pages (from-to)711-718
Number of pages8
JournalJournal of Leukocyte Biology
Volume85
Issue number4
DOIs
StatePublished - Apr 1 2009

Fingerprint

Proteoglycans
Arthritis
Nucleotides
Joint Diseases
Joints
Inflammation
Acetylmuramyl-Alanyl-Isoglutamine
T-Lymphocytes
Adaptive Immunity
Colitis
Innate Immunity
Transgenic Mice
Epitopes
B-Lymphocytes
Antigens

Keywords

  • Inflammatory arthritis
  • Knockout
  • Mice
  • NOD2
  • TCR transgenic

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis. / Rosenzweig, Holly; Jann, M. M.; Glant, T. T.; Martin, Tammy; Planck, Stephen; Van Eden, W.; Van Kooten, P. J S; Flavell, R. A.; Kobayashi, K. S.; Rosenbaum, James (Jim); Davey, Michael.

In: Journal of Leukocyte Biology, Vol. 85, No. 4, 01.04.2009, p. 711-718.

Research output: Contribution to journalArticle

@article{aed14e615cbe468899088e79eea27fb3,
title = "Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis",
abstract = "In addition to its role in innate immunity, nucleotide oligomerization domain 2 (NOD2) has been shown to play a suppressive role in models of colitis. Notably, mutations in NOD2 cause the inherited granulomatous disease of the joints called Blau syndrome, thereby linking NOD2 with joint disease as well. However, the role of NOD2 in joint inflammation has not been clarified. We demonstrate here that NOD2 is functional within the mouse joint and promotes inflammation, as locally or systemically administered muramyl dipeptide (MDP; the NOD2 agonist) resulted in significant joint inflammation that was abolished in NOD2-deficient mice. We then sought to investigate the role of NOD2 in a mouse model of inflammatory arthritis dependent on adaptive immunity using TCR-transgenic mice whose T cells recognized the dominant epitope of proteoglycan (PG). Mice immunized with PG in the presence of MDP developed a more severe inflammatory arthritis and histopathology within the joints. Antigen-specific activation of splenocytes was enhanced by MDP with respect to IFN-γ production, which would be consistent with the Th1-mediated disease in vivo. Intriguingly, NOD2 deficiency did not alter the PGinduced arthritis, indicating that NOD2 does not play an essential role in this model of joint disease when it is not activated by MDP. In conclusion, we demonstrate that in a model of inflammatory arthritis dependent on T and B cell priming, NOD2 activation potentiates disease. However, the absence of NOD2 does not alter the course of inflammatory arthritis, in contrast to models of intestinal inflammation.",
keywords = "Inflammatory arthritis, Knockout, Mice, NOD2, TCR transgenic",
author = "Holly Rosenzweig and Jann, {M. M.} and Glant, {T. T.} and Tammy Martin and Stephen Planck and {Van Eden}, W. and {Van Kooten}, {P. J S} and Flavell, {R. A.} and Kobayashi, {K. S.} and Rosenbaum, {James (Jim)} and Michael Davey",
year = "2009",
month = "4",
day = "1",
doi = "10.1189/jlb.0808478",
language = "English (US)",
volume = "85",
pages = "711--718",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "4",

}

TY - JOUR

T1 - Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis

AU - Rosenzweig, Holly

AU - Jann, M. M.

AU - Glant, T. T.

AU - Martin, Tammy

AU - Planck, Stephen

AU - Van Eden, W.

AU - Van Kooten, P. J S

AU - Flavell, R. A.

AU - Kobayashi, K. S.

AU - Rosenbaum, James (Jim)

AU - Davey, Michael

PY - 2009/4/1

Y1 - 2009/4/1

N2 - In addition to its role in innate immunity, nucleotide oligomerization domain 2 (NOD2) has been shown to play a suppressive role in models of colitis. Notably, mutations in NOD2 cause the inherited granulomatous disease of the joints called Blau syndrome, thereby linking NOD2 with joint disease as well. However, the role of NOD2 in joint inflammation has not been clarified. We demonstrate here that NOD2 is functional within the mouse joint and promotes inflammation, as locally or systemically administered muramyl dipeptide (MDP; the NOD2 agonist) resulted in significant joint inflammation that was abolished in NOD2-deficient mice. We then sought to investigate the role of NOD2 in a mouse model of inflammatory arthritis dependent on adaptive immunity using TCR-transgenic mice whose T cells recognized the dominant epitope of proteoglycan (PG). Mice immunized with PG in the presence of MDP developed a more severe inflammatory arthritis and histopathology within the joints. Antigen-specific activation of splenocytes was enhanced by MDP with respect to IFN-γ production, which would be consistent with the Th1-mediated disease in vivo. Intriguingly, NOD2 deficiency did not alter the PGinduced arthritis, indicating that NOD2 does not play an essential role in this model of joint disease when it is not activated by MDP. In conclusion, we demonstrate that in a model of inflammatory arthritis dependent on T and B cell priming, NOD2 activation potentiates disease. However, the absence of NOD2 does not alter the course of inflammatory arthritis, in contrast to models of intestinal inflammation.

AB - In addition to its role in innate immunity, nucleotide oligomerization domain 2 (NOD2) has been shown to play a suppressive role in models of colitis. Notably, mutations in NOD2 cause the inherited granulomatous disease of the joints called Blau syndrome, thereby linking NOD2 with joint disease as well. However, the role of NOD2 in joint inflammation has not been clarified. We demonstrate here that NOD2 is functional within the mouse joint and promotes inflammation, as locally or systemically administered muramyl dipeptide (MDP; the NOD2 agonist) resulted in significant joint inflammation that was abolished in NOD2-deficient mice. We then sought to investigate the role of NOD2 in a mouse model of inflammatory arthritis dependent on adaptive immunity using TCR-transgenic mice whose T cells recognized the dominant epitope of proteoglycan (PG). Mice immunized with PG in the presence of MDP developed a more severe inflammatory arthritis and histopathology within the joints. Antigen-specific activation of splenocytes was enhanced by MDP with respect to IFN-γ production, which would be consistent with the Th1-mediated disease in vivo. Intriguingly, NOD2 deficiency did not alter the PGinduced arthritis, indicating that NOD2 does not play an essential role in this model of joint disease when it is not activated by MDP. In conclusion, we demonstrate that in a model of inflammatory arthritis dependent on T and B cell priming, NOD2 activation potentiates disease. However, the absence of NOD2 does not alter the course of inflammatory arthritis, in contrast to models of intestinal inflammation.

KW - Inflammatory arthritis

KW - Knockout

KW - Mice

KW - NOD2

KW - TCR transgenic

UR - http://www.scopus.com/inward/record.url?scp=65249170022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249170022&partnerID=8YFLogxK

U2 - 10.1189/jlb.0808478

DO - 10.1189/jlb.0808478

M3 - Article

C2 - 19129483

AN - SCOPUS:65249170022

VL - 85

SP - 711

EP - 718

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 4

ER -